Nebenwirkungen · Rivastigmine 1 A Pharma
Rivastigmine 1 A Pharma 1.5 mg hard capsules Rivastigmine 1 A Pharma 3 mg hard capsules Rivastigmine 1 A Pharma 4.5 mg hard capsules Rivastigmine 1 A Pharma 6 mg hard capsules · Abschnitt 4.8 · PDF-Seite 8
HOS-212441 · Präparat HOS-154894
Psychiatric disorders Common Insomnia Common Anxiety Common Restlessness Common Hallucination, visual Common Depression Not known Aggression Nervous system disorders Very common Tremor Common Dizziness Common Somnolence Common Headache Common Parkinson’s disease (worsening) Common Bradykinesia Common Dyskinesia Common Hypokinesia Common Cogwheel rigidity Uncommon Dystonia Not known Pleurothotonus (Pisa syndrome) Cardiac disorders Common Bradycardia Uncommon Arial fibrillation Uncommon Atrioventricular block Not known Sick sinus syndrome Vascular disorders Common Hypertension Uncommon Hypotension
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-20T13:50:00Z · SHA-256 131a9504ea601ff9f929650be1df38b3f3e958ac8aed8146800bb83c92474fa3 · Passage 790429181e3e0ec7f279bf9c2e611a21a7befde344a48a6d77e97901ddde861f · Zeichen 4785–6472 im Abschnitt